Vasoactive Drugs

The purpose of vasoactive drugs in the ICU is to improve the mean arterial pressure (MAP) and cardiac output (CO) by affecting left ventricular contractility, volume status, and systemic vascular resistance (SVR). MAP is related to CO and SVR by an equation. Vasopressors are generally indicated in t...

Full description

Saved in:
Bibliographic Details
Published inMount Sinai Expert Guides pp. 82 - 88
Main Authors Vaidya, Ajay S, Gidwani, Umesh K
Format Book Chapter
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 19.01.2021
Subjects
cardiac output
circulatory shock
mean arterial pressure
systemic vascular resistance
vasoactive drugs
vasoactive medications
Online AccessGet full text

Cover

More Information
Summary:The purpose of vasoactive drugs in the ICU is to improve the mean arterial pressure (MAP) and cardiac output (CO) by affecting left ventricular contractility, volume status, and systemic vascular resistance (SVR). MAP is related to CO and SVR by an equation. Vasopressors are generally indicated in the setting of circulatory shock. There are four different types of shock: cardiogenic, distributive, hypovolemic, and obstructive. Mixed forms of shock can also occur. Vasoactive medications often work as agonists or antagonists of adrenergic or parasympathetic receptors. These selected receptors represent the principal targets for vasoactive therapy in the intensive care setting. Physical examination, urine output, laboratory testing, imaging, and invasive hemodynamic monitoring can be important tools to differentiate the nature of the patient's shock.
ISBN:9781119293262
111929326X
DOI:10.1002/9781119293255.ch12